English-language, randomized, placebo-controlled trials of oral phenylpropanolamine in adults with extractable data on pulse or blood pressure were studied.

Phenylpropanolamine is commonly found in appetite suppressants and cough or cold remedies. Case reports have linked the use of products containing phenylpropanolamine to hemorrhagic stroke, often a ...

For decades, the sympathomimetic phenylpropanolamine (PPA; ±-norepinephrine) was an active ingredient found in popular children's over-the-counter (OTC) cold, cough, and allergy medications. To ...

Learn everything you need to know about Chlorpheniramine and Phenylpropanolamine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on ...

Read the side effects of Chlorpheniramine and Phenylpropanolamine as described in the medical literature. In case of any doubt consult your doctor or pharmacist.

Phenylpropanolamine (PPA) Market report provides depth analysis of the market recent developments and comprehensive competitive landscape created by the COVID19/CORONA Virus pandemic.

Background: Phenylpropanolamine (PPA), a synthetic sympathomimetic agent, is a common ingredient in appetite suppressants and over-the-counter cough and cold remedies.

To the Editor: The request by the Food and Drug Administration (FDA) for the voluntary withdrawal of all products containing phenylpropanolamine on the basis of the data of Kernan et al. (Dec. 21 ...

The FDA is taking steps to remove phenylpropanolamine hydrochloride from all drug products due to the risk of hemorrhagic stroke.

The US Food and Drug Administration has issued a warning about the danger of phenylpropanolamine (PPA), a decongestant and appetite suppressant that occurs in various over-the-counter and prescription ...

Claim: Drug products containing PPA (phenylpropanolamine) were pulled from the market due to FDA concerns over a possible connection to strokes. All drugs containing PHENYLPROPANOLAMINE (PPA) are ...

What is the basis of the recently released precaution regarding the pediatric use of drugs containing phenylpropanolamine?